B7-33 Peptide For Sale for study use only. We supply US-Made, pure and safe B7-33 at incredible prices online!
B7-33 peptide has gained considerable attention in the research community due to its potential therapeutic benefits for various fibrotic diseases. As a result, many researchers are looking to buy B7-33 peptide for their experiments. USA Peptides is a reliable source for purchasing research chemicals, including B7-33 peptide.
What is B7-33?
B7-33 is a peptide consisting of 33 amino acids that have been derived from the extracellular domain of the B7-H3 protein. B7-H3 is a member of the B7 family of co-stimulatory molecules that play an important role in regulating immune responses. B7-33 has been found to exhibit potent anti-fibrotic effects, making it a promising candidate for treating various fibrotic diseases.
What are the Benefits of B7-33?
B7-33 has been found to reduce fibrosis in animal studies by roughly 50%. This reduction in fibrosis has led to prolonged survival following injury and offers the first new means of treating heart failure in 20 years. B7-33 has also been shown to reduce fibrosis in other organs like the lungs and kidneys, making it a potential therapeutic option for various diseases.
What is the Molecular Weight of B7-33?
The molecular weight of B7-33 is approximately 3.8 kDa. This small size makes it easier to penetrate tissues and reach its target sites.
How Does B7-33 Work?
B7-33 works by inhibiting the proliferation of fibroblasts and reducing the production of extracellular matrix proteins like collagen. This mechanism of action makes it a potent anti-fibrotic agent that can prevent the progression of fibrotic diseases. B7-33 has also been found to have an immunomodulatory effect by reducing the production of pro-inflammatory cytokines.
In conclusion, B7-33 peptide is a promising molecule that has shown potent anti-fibrotic effects. It is under active research and investigation as a means of reducing fibrosis in various acute and chronic diseases. B7-33 has the potential to offer a new means of treating fibrotic diseases and improving patient outcomes.